Kangmei Pharma | 600518 - 贸易债权人

金融业

CNY

CNY 13.31B

现金及等价物

CNY 1.23B

CNY 841.45M

CNY 6.8B

CNY 5.38B

CNY 173.71M

CNY -12.72M

CNY -12.72M

6.37K

EPS每股收益

CNY 0

股本和储备

CNY 7.31B

CNY 238.34M

债务利息支出

CNY 1.82M

CNY 2.44M

CNY 68.57M

CNY 18.85B

CNY -16.56M

CNY 1.09B

CNY -10.94M

普通股股本

CNY 13.83B

1.11K

CNY -14.01M

CNY 1.08B

销售和管理费用

CNY 237.06M

CNY 2.38B

贸易债权人

CNY 2.46B

应收帐款人

CNY 2.92B

	贸易债权人	更改		日
Akebia Therapeutics	USD 8.39M		12.8M	2026-03
Alaunos Therapeutics	USD 400K		213K	2026-03
Avita Medical	AUD 8.96M		1.69M	2025-12
Cspc Pharmaceutical	CNY 2.32B		236.83M	2025-12
Dianthus Therapeutics	USD 5.27M		4.45M	2026-03
Genomma Lab Internacional	MXN 1.7B		55.97M	2026-06
Hypermarcas	BRL 970.38M		387.18M	2026-03
Ionis Pharmaceuticals	USD 47.7M		21.67M	2026-06
IQVIA Holdings	USD 3.61B		31M	2026-06
Jiangsu Hengrui	CNY 2.33B		64.06M	2026-03
Kangmei Pharma	CNY 2.46B		153.5M	2026-03
Moderna	USD 167M		6M	2026-06
Organon & Co	USD 983M		31M	2026-03
Revvity	USD 169.68M		15.78M	2026-03
Sh Fosun Pharma	CNY 4.62B		237.97M	2026-03
Tectonic Therapeutic	USD 2.55M		1.46M	2026-03
Viatris	USD 1.2B		93.9M	2026-03
Wuxi Apptec	CNY 2.85B		401.85M	2026-03
Xeris Pharmaceuticals	USD 11.47M		8.39M	2026-03
Zz Pientze Pharmaceu	CNY 457.05M		59.09M	2026-03